Alkermes Plc news

   Watch this stock
Showing stories 1 - 10 of about 65   

Articles published

ALKS 51.30 +1.69 (3.41%)
price chart
Alkermes Plc Shares Gap Down Following Insider Selling (ALKS)
Alkermes Plc logo Alkermes Plc (NASDAQ:ALKS)'s share price gapped down before the market opened on Tuesday following insider selling activity, AnalystRatings.
Alkermes Plc COO Gordon G. Pugh Sells 14577 Shares (ALKS)
Alkermes Plc logo Alkermes Plc (NASDAQ:ALKS) COO Gordon G. Pugh sold 14,577 shares of the stock in a transaction that occurred on Thursday, October 23rd.
Alkermes plc Reports Third Quarter 2014 Financial Results  MarketWatch
Alkermes Plc (ALKS) Releases Quarterly Earnings Results, Beats Estimates By ...  Mideast Time
Related articles »  
Alkermes Plc Shares Gap Down on Insider Selling (ALKS)
Alkermes Plc logo Alkermes Plc (NASDAQ:ALKS) shares gapped down prior to trading on Tuesday following insider selling activity, StockRatingsNetwork reports.
Alkermes Plc (ALKS) Releases FY14 Earnings Guidance
Alkermes Plc logo Alkermes Plc (NASDAQ:ALKS) issued an update on its FY14 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $0.19-0.32 for the period, compared to the Thomson Reuters ...
Alkermes Plc Shares Up 3.5% on Earnings Beat (ALKS)
Alkermes Plc logo Shares of Alkermes Plc (NASDAQ:ALKS) shot up 3.5% during trading on Wednesday following a stronger than expected earnings report, Analyst Ratings.
Alkermes Plc (ALKS) to Release Quarterly Earnings on Wednesday
Alkermes Plc logo Alkermes Plc (NASDAQ:ALKS) is set to issue its quarterly earnings data on Wednesday, October 29th.
News Review � Quest Diagnostics, (NYSE:DGX), Alkermes, (NASDAQ:ALKS ...  Techsonian (press release)
Related articles »  
Alkermes plc (ALKS) NDA for Aripiprazole Lauroxil Accepted by FDA
Alkermes plc (Nasdaq: ALKS) announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for aripiprazole lauroxil, the company's investigational, novel, once-monthly injectable atypical ...
Alkermes' New Drug Application for Aripiprazole Lauroxil for Treatment ...  Business Wire (press release)
Related articles »  
Alkermes Plc Shares Up 3.5% Following Strong Earnings (ALKS)
Receive News & Ratings for Alkermes Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alkermes Plc and related companies with Analyst Ratings Network's FREE daily email newsletter.
Alkermes Plc Given Consensus Recommendation of "Buy" by Brokerages ...
Alkermes Plc logo Shares of Alkermes Plc (NASDAQ:ALKS) have been given a consensus rating of �Buy� by the eight ratings firms that are presently covering the stock, AmericanBankingNews.
Related articles »  
Alkermes Plc Receives Average Rating of "Hold" from Brokerages (NASDAQ ...
Alkermes Plc logo Shares of Alkermes Plc (NASDAQ:ALKS) have received a consensus recommendation of �Hold� from the seven analysts that are presently covering the stock, Stock Ratings Network.
Worth Watching Stocks-Alkermes Plc (NASDAQ:ALKS),ADT Corp (NYSE:ADT ...  Techsonian (press release)
News Round Up- ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Cubist ...  eMarketsDaily
Related articles »